Parent and group
- EDG België Holding84.73%
LAB@MOND
ActiveSummary
LAB@MOND has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €91,698 and a net result of €159,866. Equity has been stable since 2018 (±0.3% per year). Its solvency ranks better than 27% of 274 sector peers (NACE 32, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Overview
Official details
Source: KBO- Status
- Active since 01-08-2013 Normal situation
- Activity
- Manufacture of medical and dental instruments and supplies NACE 32500and 1 other
- Joint committee
- 330.03 Paritair Comité voor de gezondheidsinrichtingen en -diensten · annual accounts 2025
- Establishment units
- 2.237.236.308 2018 Antwerpen, since 01-08-2013
- 2.315.534.213 9830 Sint-Martens-Latem, since 01-04-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 01-12-2025
Board and ownership
Board
- BELIVManaging director · permanent representative Benedikt Vernaillen
- DentcoDirector · since 02-11-2021 · permanent representative Tommie Van de Velde
- Tandarts Alexander DeclerckDirector · since 02-11-2021
Shareholders
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.3%
Annual accounts 2025
- Gross margin
- €603,491
- ▲ 1.5%
- Turnover
- ≈ €1.4m
- estimated
- Profit
- €159,866
- ▲ 38.0%
- Equity
- €91,698
- ▲ 1.0%
- Total assets
- €426,878
- ▼ 1.6%
- Employees on 31-12-2025
- 4
- =
Score breakdownraises riskSize: 4.2 FTE, total assets €426,878lowers riskLiquidity: current ratio 0.93, cash €86,766Founded in 2013Figures for financial year 2025 (filed on 17-07-2026)Show the evidence
Checked score
Score 2025
85
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 49% of micro companies in other manufacturing (NACE 32)
Financial strength · tick: 2024
Strong
Solvency
46=
equity 21.5% of total assets
Liquidity
35-5
short-term debt 74.3% · cash 20.3%
Profitability
100=
return on assets 37.5%
Bankruptcy probability within 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.4%
01-2025: 0.4%● unchanged vs 12-2024
02-2025: 0.4%● unchanged vs 01-2025
03-2025: 0.4%● unchanged vs 02-2025
04-2025: 0.4%● unchanged vs 03-2025
05-2025: 0.4%● unchanged vs 04-2025
06-2025: 0.4%● unchanged vs 05-2025
07-2025: 0.5%▲ +0.1 percentage points vs 06-2025highest value
08-2025: 0.3%▼ -0.2 percentage points vs 07-2025
09-2025: 0.3%● unchanged vs 08-2025
10-2025: 0.3%● unchanged vs 09-2025
11-2025: 0.3%● unchanged vs 10-2025
12-2025: 0.3%● unchanged vs 11-2025
01-2026: 0.3%● unchanged vs 12-2025
02-2026: 0.3%● unchanged vs 01-2026
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.4%▲ +0.1 percentage points vs 03-2026
05-2026: 0.4%● unchanged vs 04-2026
06-2026: 0.4%● unchanged vs 05-2026
07-2026: 0.4%● unchanged vs 06-2026
08-2026: 0.3%▼ -0.1 percentage points vs 07-2026lowest value
09-2026: 0.3%● unchanged vs 08-2026lowest value
10-2026: 0.3%● unchanged vs 09-2026lowest value
11-2026: 0.3%● unchanged vs 10-2026lowest value
Credit of up to €7,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.93 (0.84 in 2024), below 1. Short-term debt is 74.3% and cash 20.3% of total assets. 78.5% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro). It does better than 31% of them on solvency, 27% on liquidity, 93% on profitability and 43% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-07-2026, 14 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
14 days early
2024
13 days early
2023
12 days late
2022
14 days early
2021
16 days early
2020
64 days early
2019
7 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 17 days before the deadline. In the sector (NACE 32), the median for financial year 2024 was 2 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
Key points
- Positive: 8 profitable years in a rowprofit 2025: €159,866 8 years View
Recent changes
- · Gazette deed 1 director appointed, 1 director resigningResignation: Dentco BV (director) · Permanent representatives: Tommie Van de Velde and Liesbet Cabooter · Appointment: Dentco BV (director)
- · Gazette deed 4 directors appointed, 2 directors resigningChange of role: BELIV BV, from director to b bestuurder · Resignation: COPIAS BV (director) · Appointments: Dentco BV (a bestuurder) and Tandarts Alexander Declerck CommV (a bestuurder)
- · Gazette deed Incorporation
Companies linked to LAB@MOND
Comparable companies
These companies have the same main activity as LAB@MOND: manufacture of medical and dental instruments and supplies (NACE 32500). They are comparable in size and age: total assets between €439,000 and €688,000, founded between 2010 and 2018.
| Company | Total assets | Gross margin |
|---|---|---|
| LAB@MOND Antwerpen | €426,878 | €603,491 |
| OPTIC BARCHON Blégny | €588,654 | €548,768 |
| ORTHO PRODUCTIONS Boutersem | €688,094 | €600,048 |
| General MediQs Torhout | €684,666 | €467,622 |
| LABO DENTAIRE GUILLITTE Esneux | €438,501 | €510,236 |
| ORTHOPEDIE KESTELYN Oudenaarde | €607,677 | €347,693 |
| Maison Luc Médical Brussel | €519,574 | €454,471 |
Key facts about LAB@MOND
- What is the company number of LAB@MOND?
- The company number of LAB@MOND is 0537.280.525. The VAT number is the same number with BE in front: BE 0537.280.525.
- Where is LAB@MOND based?
- The registered office is at Pater Pirestraat 50, 2018 Antwerpen.Company details
- What does LAB@MOND do?
- According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
- What is the legal form of LAB@MOND?
- The legal form of LAB@MOND is Private limited company (BV).
- When was LAB@MOND founded?
- LAB@MOND was founded on 01-08-2013.
- Is LAB@MOND still active?
- Yes, LAB@MOND is an active enterprise in the KBO register.
- How many employees does LAB@MOND have?
- LAB@MOND had an average of 4.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does LAB@MOND fall under?
- In its 2025 annual accounts, LAB@MOND states joint committee 330.03 (Paritair Comité voor de gezondheidsinrichtingen en -diensten).
- What is the turnover of LAB@MOND?
- The turnover in financial year 2025 is ≈ €1.4m. This figure is estimated from the gross margin of €603,491 and 2,281 comparable companies of the same size. It probably lies between €860,000 and €2.4m. It is a rough estimate.
- Is LAB@MOND profitable?
- In financial year 2025, LAB@MOND made a profit of €159,866.
- Where can I find the annual accounts of LAB@MOND?
- LAB@MOND filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of LAB@MOND due?
- LAB@MOND must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See the other companies in the same group.EDG België Holding · 16 companies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.